middle.news
EMVision Expands emu™ Trial to Validate Acute Ischaemia Detection
8:52am on Monday 11th of May, 2026 AEST
•
Healthcare
Read Story
EMVision Expands emu™ Trial to Validate Acute Ischaemia Detection
8:52am on Monday 11th of May, 2026 AEST
Key Points
Acute ischaemia detection added to pivotal trial
Over 125 patients enrolled across eight hospitals
FDA pre-submission engagement planned for endpoint expansion
Regional Benefit Study progressing with government funding
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE